Home » News » Drug Sponsors » Regeneron, BioMed Realty break ground on New York R&D facility

Regeneron, BioMed Realty break ground on New York R&D facility

Monday, October 28, 2013

Regeneron Pharmaceuticals and BioMed Realty Trust have broken ground on a new 300,000-square-foot build-to-suit research facility for Regeneron at BioMed Realty’s The Landmark at Eastview campus in Westchester County, New York.

Upon completion, Regeneron will lease and fully occupy for a 15-year term the to-be-built laboratory and office space adjacent to its other Landmark facilities. BioMed Realty estimates the new buildings will be occupied by Regeneron in late 2015.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!